Open AccessSurvival After Trimodality Therapy in Patients With Locally Advanced Esophagogastric Adenocarcinoma
Author(s) -
Smita Sihag,
Tamar Nobel,
Meier Hsu,
Sergio De La Torre,
Kay See Tan,
Yelena Y. Janjigian,
Geoffrey Yuyat Ku,
Laura H. Tang,
Abraham J. Wu,
Steven Brad Maron,
Manjit S. Bains,
David R. Jones,
Daniela Molena
Publication year - 2020
Publication title -
annals of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.153
H-Index - 309
eISSN - 1528-1140
pISSN - 0003-4932
DOI - 10.1097/sla.0000000000004638
Subject(s) - medicine , clinical endpoint , esophagectomy , survival analysis , proportional hazards model , stage (stratigraphy) , adenocarcinoma , neoadjuvant therapy , clinical trial , oncology , surgery , gastroenterology , esophageal cancer , cancer , breast cancer , paleontology , biology
To evaluate whether pCR exclusively defines major pathologic response to treatment with improved survival.